Lv51
1526 积分 2023-04-21 加入
Linker-Driven Sampling of PROTAC-Induced Ternary Complexes
6小时前
已完结
Expanding the potential of antibody–drug conjugates in gastrointestinal malignancies: beyond HER2 targets
11天前
已关闭
QT Prolongation Risk of Antibody–Drug Conjugates
12天前
已完结
Discovery of Novel NLRP3 Inflammasome Inhibitors Composed of an Oxazole Scaffold Bearing an Acylsulfamide
18天前
已完结
Evolving Treatments and Resistance Mechanisms in Prostate Cancer Therapeutics
18天前
已完结
Development and Evaluation of 1-Hydroxypyridin-2(1 H )-one Derivatives as Antibacterial Agents against Pathogenic Pseudomonas aeruginosa
20天前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
20天前
已完结
Discovery of Elironrasib (RMC-6291), a Potent and Orally Bioavailable, RAS(ON) G12C-Selective, Covalent Tricomplex Inhibitor for the Treatment of Patients with RAS G12C-Addicted Cancers
21天前
已完结
Antibody-Mediated Delivery of BRM/BRG1 Protein Degraders Affords Strong Antitumor Efficacy in Multiple BRM-Dependent Non-Small Cell Lung Cancer Xenograft Models
23天前
已完结
Recent advances in developing targeted protein degraders
26天前
已完结
皖公网安备34019202002308
